Yong Bae Kim, MD

Professor, Department of Radiation Oncology, Yonsei Cancer Center,

Yonsei University College of Medicine, Seoul, Korea

2008~present Assistant, Associate & Full Professor, Department of Radiation Oncology,

Yonsei Cancer Center, Yonsei University Health System, Seoul, Korea

2010~2012 Visiting Scientist (Faculty), Department of Experimental Radiation Oncology, M. D. Anderson Cancer Center, Houston, Texas, U.S.A

2017~2021 Professor and Chairperson, Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University Health System, Seoul, Korea

2018~present Vice Director, Construction Operation Division for Heavy Ion therapy System, Yonsei University Health System, Seoul, Korea

2016~present NRG Oncology Co-PI, Yonsei University Health System-Severance Hospital (43027)

2017~ 2019 Director of General Affairs, Korean Society of Radiation Oncology

2019~ 2021.4 Member of board of directors, Korean Breast Cancer Society

<Publication >

Hypofractionated volumetric-modulated arc therapy for breast cancer: A propensity-score-weighted comparison of radiation-related toxicity.

Int J Cancer. 2021 Jul 1;149(1):149-157

Risk of Cardiac Disease in Patients With Breast Cancer: Impact of Patient-Specific Factors and Individual Heart Dose From Three-Dimensional Radiation Therapy Planning.

Int J Radiat Oncol Biol Phys. 2021 Jun 1;110(2):473-481.

First Experience in Korea of Stereotactic Partial Breast Irradiation for Low-Risk Early-Stage Breast Cancer.

Front Oncol. 2020 Apr 29;10:672.

Risk of Lymphedema Following Contemporary Treatment for Breast Cancer: An Analysis of

7617 Consecutive Patients From a Multidisciplinary Perspective.

Ann Surg. 2019 Jul 23

Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203.

J Clin Oncol. 2018 Aug 20;36(24):2538-2544

Tumor-related leukocytosis is associated with poor radiation response and clinical outcome in uterine cervical cancer patients.

Ann Oncol. 2016 Nov;27(11):2067-2074.

Disclosures: